Papers: 10.1155/2021/5514726

https://doi.org/10.1155/2021/5514726

Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms

Cited by: 3
Author(s): Hong Yu, Shuang Peng, Songling Han, Xi Chen, Qinghua Lyu, Lei Tao
Published: about 5 years ago

Software Mentions 2